I n mice, B cells are generated in the bone marrow after birth. Their stages of development are divided into pro-B, pre-B, and immature B cells by the sequential expression of cell surface markers and the ordered rearrangement of Ig H and L chain segments (1, 2) . Progenitor B cells undergo rearrangement of the Ig H chain locus to become pro-B cells. Subsequently, expressed mu H chains associate with surrogate L chains and the signaling molecules Ig␣ and Ig␤, forming the pre-BCR complex (2) . The pre-BCR complex plays a critical role in the clonal expansion of mu ϩ pro-B cells and differentiation to the pre-B cell stage (3, 4) . Pre-B cells undergo Ig L chain rearrangement and the resultant L chains associate with the mu H chain to form membrane-bound IgM (3) . After successful rearrangement of both H and L chain genes, the BCR, which includes Ig␣ and Ig␤, is formed and expressed on the surface of B cells. The BCR functions as an Agbinding and signal transduction molecule during further B cell development (5) .
Immature B cells emigrate from the bone marrow to the spleen, and there progress through transitional states. Transitional B cells enter splenic follicles, further differentiating to follicular (FO) 3 B cells, which comprise the majority of the mature splenic B cell population and marginal zone (MZ) B cells (5, 6) . The differentiation and maintenance of these mature B cells require signals derived from the BCR (7) . Maintenance of transitional, FO, and MZ B cell subsets are controlled by their microenvironment and interactions with other cell types (5, 8) . In mice, MZ B cells, together with metallophilic and marginal-sinus-associated macrophages, initiate a rapid first line of defense against blood-borne particulate Ags. MZ B cell responses were first thought to be primarily directed against T-independent Ags; however, recent reports indicate that MZ B cells play roles in both T-independent and -dependent immune responses. FO cells participate primarily in T-dependent Ab responses (8, 9) . Progression through B cell development depends on the combined effects of multiple regulatory genes, including Pax-5, early B cell factor (EBF), the E2A factors E12 and E47, and the Ets transcription factor, PU.1 (10) . Members of the Ets gene family are found in genomes of diverse organisms, including Drosophila, Xenopus, sea urchin, chicken, mouse, and human (11, 12) . The transcription factor Fli-1 is a member of the Ets family and is expressed in hematopoietic cells and a variety of other tissues (13, 14) . Like all members of the Ets gene family, Fli-1 has the conserved DNA-binding domain, the Ets domain. The Fli-1 gene encodes two protein products, the larger comprised of 452 aa (14, 15) . The Ets (DNA-binding) domain of Fli-1 is located between amino acids 277 and 361. Deletion analysis has identified two transcriptional regulatory domains, designated ATA and CTA, for N-terminal transcriptional and C-terminal transcriptional activation domains, respectively (16) . Ets proteins bind to DNA sequences that contain a consensus GGA(A/T) core motif (Ets-binding site) and can function as either transcriptional activators or repressors (11, 12) . Ets proteins regulate the expression of genes that are critical for the control of cellular proliferation, differentiation, and programmed cell death. Previous studies indicate that Fli-1 plays an important role in the regulation of megakaryocyte development (17) (18) (19) (20) .
Studies regarding the role of Fli-1 in immune function or dysfunction are limited. Several reports indicate that Fli-1 can bind specific Ets-binding sites and transcriptionally activate a number of genes including those encoding Egr-1, multiple megakaryocytic genes, bcl-2, mb-1, and hTERT (21) (22) (23) (24) (25) . Fli-1 can also act as a repressor of Rb and collagen 1 expression (26 -27) . Targeted constitutive disruption of the Fli-1 gene resulted in hemorrhage into the neural tube and embryonic death due in part to thrombocytopenia (28 -29) . Two-fold overexpression of the Fli-1 protein in transgenic mice resulted in the development of a lupus-like disease, including progressive immune complex-mediated renal disease and ultimately premature death from renal failure. Hypergammaglobulinemia, splenomegaly, B cell peripheral lymphocytosis, and autoantibody production (antinuclear Ab and anti-dsDNA) were prominent in these transgenic mice (30) . We previously reported that reduced expression of the Fli-1 protein in MRL/lpr mice, a murine model of lupus, significantly increased survival and decreased renal disease compared with wild-type littermates (31) . MRL/lpr mice with reduced Fli-1 expression also had decreased total serum Ig and anti-dsDNA Abs. Taken together, these studies suggested that Fli-1 plays an important role in the immune system, the B cell being an apparent target.
To assess the role of Fli-1 in lymphocyte development in vivo, we generated C57BL/6 mice that expressed a truncated Fli-1 protein (amino acids ⌬CTA /Fli-1 ⌬CTA mice. Thus, Fli-1 appears to be a negative regulator of MZ B cell development and a positive regulator of FO B cell development, possibly via, among other mechanisms, regulating surface expression of Ig␣. In addition, altered expression of E2A and Id mRNAs may also contribute to the observed increase in MZ B to FO B cell ratio. These findings also highlight a unique in vivo function for the CTA domain of Fli-1 in the regulation of B cell development and function.
Materials and Methods

Mice
Generation of the Fli-1 allele (Fli-1 ⌬CTA ) that encodes truncated Fli-1 protein (amino acids 1-384) mice has been described in detail (O. Moussa, A. LaRue, R. Abangan, Jr., X. Zhang, M. Masuya, Y. Gong, D. Spyropoulos, M. Ogawa, G. Gilkeson, and D. Watson, manuscript in preparation). The mice were backcrossed with C57BL/6 mice for at least eight generations and then used in this study. Ly5.1 mice (B6.SJL-Ptprc a Pep3 b /BoyJ) were purchased from The Jackson Laboratory for the bone marrow transplantation study. All mice were maintained in the specific-pathogen-free animal facilities of the Ralph H. Johnson Veterans Affairs Medical Center, and all animal procedures were approved by the institutional animal care and use committee.
Immunoblotting
Splenocytes, thymocytes, or purified B cells with negative selection kits (Miltenyi Biotec) from spleen cells were lysed by radioimmunoprecipitation assay buffer. Lysates were analyzed by 10% SDS-PAGE and transferred to a polyvinylidene fluoride membrane. The membrane was incubated with specific Fli-1 Ab and revealed by horseradish-conjugated goat-anti-rabbit Abs, following by the ECL detection system.
ELISA
ELISA were used to detect the Ig concentrations from mice as described previously (31) .
Chromatin immunoprecipitation (ChIP) assays
Total bone marrow (4 ϫ 10 6 cells) was isolated from wild-type and Fli-1 ⌬CTA /Fli-1 ⌬CTA mice. A ChIP assay was performed as described previously using anti-Fli1 rabbit polyclonal Ab (21) . The Ϫ160 to ϩ34 region of the mouse mb-1 promoter was amplified by real-time PCR using primers 5Ј-GGCAGGGCTCTGAGGGCTTCT-3Ј and 5Ј-TCTCCACTCAGAGC CCACACA-3Ј, specific for the proximal promoter region. Real-time PCR was conducted using a LightCycler (Roche) with the Platinum SYBR Green qPCR SuperMix UDG (Invitrogen) according to the manufacturer's instructions. PCR primers were used at a concentration of 250 nM. The cycling conditions for mb-1 were: preincubation at 50°C for 2 min, 95°C for 2 min, followed by 55 cycles of denaturation at 94°C for 10 s, annealing 57°C for 10 s, and extension at 72°C for 25 s, with a single data acquisition at the end of each extension. All ramping was done at 20°C per second. Relative expression analysis was conducted using the program LinRegPCR according to the suggested specifications.
Flow cytometry analysis and cell sorting
Single-cell suspensions were prepared from spleen, bone marrow, or thymus from mice at the age of 6 -12 wk. The cells were stained with fluorochrome-or biotin-conjugated Abs and analyzed on a FACSCalibur flow cytometer. Data were analyzed using CellQuest (BD Immunocytometry Systems) software. Transitional, FO, or MZ B cells were sorted by the MoFlo High-Performance Cell Sorter (DakoCytomation) after staining with Abs and used for RNA preparation in real-time PCR. All Abs were purchased from BD Pharmingen. 
Immunization and determination of Ig titers
B cell purification, culture, and stimulation
B cells were purified with B cell-negative selection kits from Invitrogen. The purity of B cells (over 90%) was confirmed by flow cytometry analysis. For CD23 induction, B cells were cultured in RPMI 1640 medium with 10% FBS, 2 mM L-glutamine, and 50 M 2-ME at the concentration of 10 6 cells/ml. Cells were stimulated with 50 ng/ml IL-4 (R&D Systems) and expression of CD23 was measured after 24 h by flow cytometry after staining with anti-CD23-PE Abs. For in vitro class switch assays, B cells were cultured at 10 6 cells/ml with 50 g of LPS (Sigma-Aldrich) and recombinant murine IL-4 at 50 ng/ml to induce switching to IgG1, with LPS alone to induce switching to IgG3 and IgG2b, or with LPS and IFN-␥ at 10 ng/ml (eBioscience) to induce switching IgG2a. The percentage of IgG1, IgG3, IgG2a, and IgG2b expression was measured by flow cytometric analysis after 4 days of stimulation and staining with FITC-conjugated anti-mouse IgG1, IgG3, IgG2a, or IgG2b and PE-conjugated anti-B220.
In vivo proliferation assays
A total of 10 5 purified B cells were dispensed in a 96-well plate at 100 l/well and cultured with RPMI 1640 medium with 10% FBS, 2 mM L-glutamine, and 50 M 2-ME. Cells were stimulated with 20 or 40 g/ml anti-mouse IgM (goat F(abЈ) 2 
Real-time PCR
Total RNA was prepared from bone marrow, splenic cells, or purified B cells for real-time PCR analysis. A total of 2 g of RNA was used to synthesize cDNA (SuperScript First-Strand Synthesis System; Invitrogen). Real-time PCR was performed in duplicate using Platinum SYBR Green qPCR SuperMix UDG (Invitrogen) according to the manufacturer's instructions, with three independent RNA preparations. PCR was done using the LightCycler (Roche) and relative expression analysis was conducted using the program LinRegPCR according to the suggested specifications (34) . The cycling conditions for all genes were: preincubation at 50°C for 2 min, 95°C for 2 min, followed by 30 -50 cycles of denaturation at 94°C for 5 s, annealing at 1°below the lowest temperature for a given primer pair (Table I) 
Statistical analysis
Quantitative data are expressed as mean Ϯ SD. Statistical analysis was performed using the two-tailed Student t test.
Results
Generation of
Because complete disruption of the Fli-1 gene is embryonic lethal, we generated a new Fli-1 allele (Fli-1 ⌬CTA ) that encodes a truncated Fli-1 protein (amino acids 1-384) lacking the CTA domain and used homozygous mutant mice to evaluate the role of Fli-1 in normal lymphocyte development. Removal of this domain of Fli-1 reduces overall in vitro transcriptional activation activity by 40 -50% (16 ⌬CTA /Fli-1 ⌬CTA mice were slightly lower than in wild-type mice, the difference was not statistically significant (Fig. 1B) .
Fli-1 deficiency affects pre-B cell development in bone marrow
To further characterize the impact of Fli-1 CTA deficiency on B cell development, bone marrow cells were isolated from the femurs of wild-type and Fig. 3B ). The total number of FO B cells in the spleens from Fli-1 ⌬CTA /Fli-1 ⌬CTA mice was significantly less than in wild-type controls (Fig. 3A) . Overall, the intensity of cell surface CD23 expression on all splenic B cells was reduced in Fli-1 ⌬CTA /Fli-1 ⌬CTA mice compared with wild-type mice (Fig. 3C) . It has been reported that CD23 is up-regulated by IL-4 (36 cells, including CD1d and CD9 (Fig. 3D) . The absolute number of MZ B cells in spleens from Fli-1 ⌬CTA /Fli-1 ⌬CTA mice was also significantly higher than in wild-type mice (Fig. 3A) 
B cell-autonomous Fli-1 defect affects B cell development in
The reduced number of FO B cells and increased number of transitional and MZ B cells could be the result of an intrinsic Fli-1 defect in the B cells themselves or due to influences of Fli-1 deficiency on the splenic microenvironment (non-B cells). To distinguish between these two possibilities, 1 ϫ 10 6 bone marrow cells from wild-type or Fli-1 ⌬CTA /Fli-1 ⌬CTA mice with the Ly5.2 (CD45.2) genotype were transferred into sublethally irradiated B6 mice with the Ly5.1 (CD45.1) genotype. The mice were sacrificed 12 wk after transplantation and the spleen cells were analyzed by flow cytometry. As shown in Fig. 5A , over 94% of spleen cells from the recipients were CD45.2 ϩ indicating that the reconstituting B cells in the recipients were derived from donor bone marrow. B6 Ly5.1 recipients that received wild-type bone marrow had numbers of MZ B cells and FO B cells similar to those of wildtype mice (Fig. 5B) . In contrast, the B6 Ly5.1 mice that received (10, 40 -41) . Real-time RT-PCR was used to examine the expression of multiple transcripts in mRNA prepared from total bone marrow and purified B cells (Fig. 6B) . Id proteins are negative regulators of transcription factors E2A and Pax-5 (40, 41). Although PU.1 and EBF were not significantly altered in the Fli-1-deficient mice, the expression of E2A and Pax-5 mRNA was significantly reduced and Id1 and Id2 mRNA was significantly increased in RNA prepared from bone marrow of Fli-1-deficient vs wild-type mice (Fig. 6B) . E2A transcript levels were reduced in RNA prepared from splenic B cells of the Fli-1-deficient mice, although the values did not reach statistical significance. Id2 transcripts were statistically significantly increased in total RNA prepared from bone marrow and purified splenic B cells (Fig. 6B (Fig. 6C) . Transitional B cells demonstrated higher expression of Fli-1 than MZ and FO B cells (Fig. 6C) .
Programmed cell death is a critical process in B lymphocyte development. We found that Bcl-x L and Bcl-2 expression was decreased in Fli-1 ⌬CTA /Fli-1 ⌬CTA mice compared with wild-type controls (Fig. 6B) . We did not, however, detect differences in in vivo or in vitro apoptosis between wild-type and Fli-1 ⌬CTA /Fli-1 ⌬CTA mice (data not shown).
As noted above (Fig. 3C) ( Fig. 6B) . At this time, it is unclear whether the reduction in CD23 and CD19 is a primary effect of Fli-1 deficiency or is secondary to the impact of Fli-1 on B cell development.
Next, we asked whether the reduced gene expression observed reflects decreased binding of Fli-1 ⌬CTA to Fli-1-responsive promoters. For this, we examined whether truncated Fli-1 protein binds the mb1 promoter in vivo in B cells. After immunoprecipitation with a Fli-1-specific Ab that binds both native Fli-1 and truncated Fli-1, enrichment of the endogenous promoter fragments in each sample was detected by PCR amplification. As a positive control, 5% of the input chromatin was used as a template. Normal rabbit IgG was used as a negative control (Fig. 6D) The Ϫ160 to ϩ34 region of the mouse mb-1 promoter was amplified by real-time PCR using mb-1 primers specific for the proximal promoter region as outlined in Materials and Methods. Relative expression analysis was conducted using the program LinRegPCR according to the suggested specifications. As a positive control, 5% of the input chromatin was used as a template. Normal rabbit IgG was used as a negative control.
cell-independent and -dependent Ags in Fli-1 ⌬CTA /Fli-1 ⌬CTA mice compared with wild-type controls. Mice were injected with 50 g of T cell-independent Ag TNP-Ficoll or T cell-dependent Ag TNP-KLH mixed with CFA i.p. Mice immunized with T cell-dependent TNP-KLH were boosted with 50 g of TNP-KLH mixed with IFA 1 wk after the first immunization. Induced TNP-specific Abs were measured 7, 14, and 21 days after immunization. Fli-1 ⌬CTA /Fli-1 ⌬CTA mice produced significantly lower levels of IgG1 Abs against the T cell-dependent Ag compared with wild-type control mice. Fli-1 ⌬CTA /Fli-1 ⌬CTA mice, however, produced higher levels of IgM Abs against the T cell-independent Ag, and higher levels of IgG3 Abs against both T cell-dependent and -independent Ags (Fig. 8) analyzed by flow cytometry. There were no significant differences in mature CD4 
Discussion
Prior experiments in Fli-1-transgenic and heterozygous knockout mice indicated that Fli-1 has significant effects on immune function, specifically B cell function (30, 31 The pre-B cell population was significantly lower in Fli-1
⌬CTA mice compared with wild-type mice, suggesting that Fli-1 plays a critical role in the differentiation of pro-to pre-B cells. Formation of the pre-BCR is required for the clonal expansion of pro-B cells and differentiation to the pre-B cell stage (3, 4) . Disruption of pre-BCR signaling resulted in a significant reduction of pre-B cells in mice (43) . Complete knockout of the Pax-5 gene resulted in arrest at the early pro-B cell stage and lack of pro-to pre-B cell differentiation (44, 45) . Elevated Id1 contributed to a reduced pre-B cell population (46, 47) . Disruption of Egr-1 and E2A genes also significantly reduced pre-B cell populations (42, 48, 49) . We found that expression of mb-1, Pax-5, E2A, and Egr-1 was significantly reduced and expression of Id1 was increased in bone marrow-derived cells from Fli-1 ⌬CTA /Fli-1 ⌬CTA mice compared with wild-type controls. The decrease in pre-B cells in Fli-1 ⌬CTA /Fli-1 ⌬CTA mice is likely due to the combination of decreased expression of Ig␣ (pre-BCR), Erg-1, Pax-5, and E2A or increased expression of Id (Fig. 10) . The decreased proliferative response of Fli-1-deficient B cells to BCR cross-linking indicates that a Fli-1-regulated factor is required for full BCR responsiveness. We believed that the decreased expression of Ig␣ would result in decreased intracellular Ca 2ϩ flux following BCR cross-linking. The similar response of Fli-1-deficient B cells and wild-type B cells to calcium indicates that the impact of Fli-1 expression is not at the earliest phases of BCR signaling, but further down the signal transduction pathway. Thus, it is unlikely that the decreased expression of Ig␣ alone is sufficient to explain the B cell phenotype observed in the Fli-1-deficient mice.
The (Fig. 10) . In this study, we found a significant decrease in FO B cells and increased MZ B cells in Fli-1-1 ⌬CTA /Fli-1 ⌬CTA mice. The BCRsignaling pathway is a major factor in determining the fate of mature B cells (5, 8, 51) . Disruption of BCR-signaling components blocks transition of T2 B cells to FO B cells (43, 52, 53) . Mice in which BCR signaling was impaired because of the presence of a knocked-in L chain mutation had increased numbers of MZ B cells (51) . A model was proposed to explain the defects observed in MZ and FO B cell development in these gene-disrupted animals (5, 8) . In this model, strong BCR signaling leads immature B cells to differentiate to FO B cells, while weak BCR signaling leads immature B cells to differentiate to MZ B cells. Ig␣ is one of the signaling components of the BCR and plays a very important role in the BCR-signaling pathway as noted above. Disruption of the Ig␣ cytoplasmic tail blocked generation of mature B cells (53) . Mice in which the tyrosine residues in the Ig␣ ITAM were mutated to phenylalanine exhibited enhanced Ca ϩ2 signaling downstream of the BCR and resultant decreased number of MZ B cells (52) . Fli-1 has been reported to coregulate Ig␣ expression with Pax-5 (23). In the current study, we demonstrated that Fli-1 protein can directly bind to the promoter of the mb-1 gene. Although the truncated Fli-1 protein can also bind to the promoter of mb1, it does so to a reduced extent, perhaps accounting, in part, for the decreased expression of surface Ig␣ protein and mRNA in B cells from Fli-1 ⌬CTA /Fli-1 ⌬CTA mice compared with wild-type controls. This reduced expression may contribute to "weak" BCR signaling and concomitant decreased number of FO B cells and increased number of MZ B cells observed in these mice. We also found that expression of Id genes were higher in B cells from Fli-1 ⌬CTA /Fli-1 ⌬CTA mice. Relative to BCR signaling, Id1 expression is negatively correlated with mb-1 expression (54) . Thus, elevated Id1 may contribute to the reduced FO B cell population. Notch-RBP-J signaling was reported to be involved in the fate determination of MZ B cells (55, 56) . Because we did not find significant differences in the expression of Notch 1 or its negative regulators, NUMB, NrarP, MINT, and sel-10 (data not shown), it is unlikely that Fli-1 affects MZ B cell development via aberrant Notch signaling. B cell-activating factor (BAFF) plays an important role in B cell development. BAFF-deficient mice lost all FO and MZ B cells, but B1 cell development was not affected (57, 58 We and others have demonstrated that Fli-1 is highly expressed in T cells, and expression of Fli-1 is decreased after T cell activation (61, 62) . Although the T cell population was higher in the spleen, we did not find significant differences in the stages of T cell development in the thymus in Fli-1 ⌬CTA /Fli-1 ⌬CTA mice. Because only the CTA domain was removed in Fli-1 ⌬CTA /Fli-1 ⌬CTA mice, it remains possible that, while Fli-1 is involved in the development of T cells, the CTA domain is not critical for these functions. In addition, these results suggest that this allele does not seem to regulate T cell lymphocyte lineage choice. These results also suggest that the B cell lineage differences are not secondary to T cell effects, but are rather intrinsic to B cells.
Several studies have demonstrated that stromal cells play an important role in lymphocyte development, and that gene-deficient stromal cells affect normal lymphocyte development (63, 64 (Fig. 10) . The impact of Fli-1 on B cell development is, thus, likely multifactorial, implicating BCR signaling and expression of transcription factors important for B cell lineage development/differentiation. Further studies, such as genetic reconstitution and generation of B cell-specific Fli-1-null mice, are needed to dissect the distinct mechanisms underlying the B cell effects noted. The in vivo importance of these findings in normal immunity is evidenced by the altered response to immunization of mice deficient in Fli-1 CTA expression. Furthermore, our previous report of a profound effect of Fli-1 heterozygosity on lupus development in MRL/lpr mice underscores the in vivo implications of these studies.
